Boston Scientific (BSX) SVP Emily Woodworth adds 2,930 shares in 401(k) rebalance
Rhea-AI Filing Summary
BOSTON SCIENTIFIC CORP executive Emily Woodworth, SVP, Global Controller and CAO, reported a discretionary acquisition of 2,930 shares of common stock on 2026-08-11 at $51.19 per share. The shares were acquired indirectly through a rebalance in the company’s 401(k) Retirement Savings Plan, bringing her indirect 401(k) holdings to 2,930 shares.
A separate holding entry shows 3,123 shares held directly, which includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based on the most current data available.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,930 shares
Net Buy
2 txns
Insider
Woodworth Emily
Role
SVP, Global Controller and CAO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Discretionary | Common Stock F1 | 2,930 | $51.19 | $150K |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,930 shares (Indirect, By 401(k));
Common Stock — 3,123 shares (Direct)
Footnotes (2)
- F1. Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
- F2. Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
Key Figures
Shares acquired: 2,930 shares
Acquisition price: $51.19 per share
Indirect holdings after transaction: 2,930 shares
+2 more
5 metrics
Shares acquired
2,930 shares
Discretionary 401(k) rebalance on 2026-08-11
Acquisition price
$51.19 per share
Non-derivative common stock transaction
Indirect holdings after transaction
2,930 shares
Held indirectly By 401(k) after acquisition
Direct holdings reported
3,123 shares
Directly held common stock including ESPP shares
Buy transactions
0
No open-market buy coded as P; one acquire under A/I discretionary
Key Terms
Rule 16b-3(f), 401(k) Retirement Savings Plan, Employee Stock Purchase Plan, indirect holdings
4 terms
Rule 16b-3(f) regulatory
"Discretionary transaction under Rule 16b-3(f)"
401(k) Retirement Savings Plan financial
"rebalance their holdings under the Company's 401(k) Retirement Savings Plan"
Employee Stock Purchase Plan financial
"Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
indirect holdings financial
"indirect 401(k) holdings to 2,930 shares"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Boston Scientific (BSX) executive Emily Woodworth report in this Form 4?
Emily Woodworth reported a discretionary acquisition of 2,930 BSX shares of common stock at $51.19 per share through the company’s 401(k) Retirement Savings Plan, plus an updated direct holding figure.
What are Emily Woodworth’s indirect BSX holdings after the reported transaction?
Following the 401(k) rebalance, Emily Woodworth’s indirect holdings in BSX common stock held "By 401(k)" total 2,930 shares, reflecting the discretionary acquisition reported in this Form 4.
Was the Boston Scientific (BSX) transaction made under a Rule 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked, and the transaction is described instead as a discretionary transaction under Rule 16b-3(f) tied to a 401(k) rebalance election.